ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

YGEN Yourgene Health Plc

0.515
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Yourgene Health Plc LSE:YGEN London Ordinary Share GB00BN31ZD89 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.515 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Yourgene Health Share Discussion Threads

Showing 4376 to 4399 of 5450 messages
Chat Pages: Latest  182  181  180  179  178  177  176  175  174  173  172  171  Older
DateSubjectAuthorDiscuss
23/12/2021
07:11
Today's announced contract given a 'value' of £57.5M in bidstats.
cottoner
15/12/2021
16:01
APAD: My YGEN holding is small in comparison to your own held in my growth portfolio the vast majority of my shares held in my income portfolio Sincerely hope the share price rises for you. Time for LR & co to step up to the plate if they agree share price undervalued and increase their skin in the game.
catch007
15/12/2021
14:49
maybe even a few director buys too. He seemed to agree that now would be a good buying point, so get on with it chaps, hands in pockets LR/BH/HJ, management and others. Let's remember if/when they do buy it probably won't be in the millions like many seem to think.I don't think these guys are that wealthy to be able to just put their hands on multiple or tens of thousands of ££££.
I think the run rate is a little lower and they will be nearer £31/32m at year end. but £35m sounds good.

hjb1
15/12/2021
14:35
Lyn Dafydd Rees owns 1,037,902 shares

I've got more than that!

Next time you listen to him bemoaning the share price.........

apad

apad
15/12/2021
14:33
Just watched the Investor Meet presentation always amazes me how few PI's take advantage of such opportunities, only 25 views!

Lots to like about the progress I was concerned about headcount ratcheting however the run rate is clearly delivering. Two Brokers forecasting around £27.5m FY revenue seems way out of sync when 8 months non audited is reported at £23m and we remain in a Covid sensitive world. At a run rate of £3m pm we would be looking at circa £35.5m FY Revenues.

Good questions from investors around share price and pleased to see plans for a capital markets day next March or April.

catch007
15/12/2021
13:29
For me I will give it a bit more time to see what traction they get with the US. Shouldn't take too much longer to find out, hopefully by end of March.If Labcorp adopt it in any decent way then we could be getting somewhere.Throw in the other one then it looks exciting.
birdie12
15/12/2021
11:04
Sell the company!Get 20p++ and end the years and tears.
twix386
15/12/2021
10:37
Looking like new contracts going to by flying out over the next few weeks with omicron causing havoc
bobaxe1
14/12/2021
17:03
End March is the end of the fiscal year. The budgets will start again then. Not saying that it is the reason, but the government systems were established a few hundred years ago and don't appear to have changed since that time.
redartbmud
14/12/2021
14:09
don't forget the presentation later today at 4.30.. time to ask them questions instead of on a bb.
hjb1
14/12/2021
12:04
And hilariously odx is up wonky Aim cesspit
bobaxe1
14/12/2021
12:03
Yep more great news, but its all negative to some
bobaxe1
14/12/2021
11:35
seems pretty good to me !
mikethebike4
14/12/2021
11:12
Could be extended from March
sabre6
14/12/2021
11:06
New UKHSA contract bit of a damp squib runs only until March 22 and is basically a contract extension of first award unless I am mistaken!
catch007
14/12/2021
10:59
Broadly in line with expectations:

As MJ has commented cashflow neutral is encouraging however cash has dropped to 4.7m due to higher admin costs and earn outs.

Good to see another framework contract awarded - details awaited and more to come?

Covid volumes remain strong and will drive revenues to year end. Not sure if margins are eroded as testing costs have fallen in market.

Move to mobilisation of pipeline in US should deliver medium term benefits. Disappointing to note US diagnostic partners names remain under curfew.....investors need to know this key information.

Focus on building existing businesses is interesting as Lyn Rees has acquisitive intentions. I would prefer building current business by scale and net profitability for the time being.

SP seems to be disconnected from a solid growth story a hold for me rather than further additions until direction of travel becomes clear.

All in all several positives from todays RNS GLA

catch007
14/12/2021
08:51
Read & re-read that RNS. Added.
folderboy
14/12/2021
08:45
Well said NgenUsual pre rns rise and post rns retrace. It's as regular as day follows night.Need material news with full details. Await US names and promise of further news to come. Sigh! So predictable, so I did!!!
twix386
14/12/2021
07:58
Looks like they have been told no more dilution as they report that future funds will be through other channels and not dilution, so good news there too.
birdie12
14/12/2021
07:51
Cash flow improved from outflow to neutral. One of my top concerns with small caps is repeated fund raising and dilution. Covid testing is going to be around for sometime yet and revenue from testing will compensate for effects on core business.
melton john
14/12/2021
07:41
Great rns what's the expected uplift here
bobaxe1
14/12/2021
07:26
FY expectations lifted again.COVID testing continues.New govt sequencing contract.Growth returning to core business.Looks solid to me.All the best.
ngen yap
13/12/2021
13:31
High volumes and a large red buy, the plot thickens
bobaxe1
12/12/2021
13:34
I am hopeful that on Tuesday we will get a progressive update from YGEN. The run rate for testing I suspect remains very strong and testing volumes will be driving revenue growth. I note several Covid testing stocks AVCT, ODX etc have been marked down heavily in recent months and Covid sentiment may well have also impacted YGEN share price though it is not a one trick pony with a strong NIPT business.

Looking for some positive framework news as it has been a 4 lot damp squib to date and also confirmation of US partners will be helpful. Unfortunately we may see further delays in global business growth with further Covid restrictions being imposed. Hoping that we may see recovery from the 12p range on the back of results. GLA

catch007
Chat Pages: Latest  182  181  180  179  178  177  176  175  174  173  172  171  Older

Your Recent History

Delayed Upgrade Clock